Implementation and Evaluation of Vector Control Methods in Kinshasa: The Case of Aedes

Launched by INSTITUTE OF TROPICAL MEDICINE, BELGIUM · May 12, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on finding better ways to control Aedes mosquitoes, which can spread diseases like dengue, chikungunya, yellow fever, and Zika. These diseases are a growing concern in Kinshasa, Democratic Republic of the Congo, where there have been outbreaks reported in the past. The researchers are testing different methods to reduce mosquito populations and will be examining their effectiveness over a 12-month period in selected households. They will also gather information about community awareness and practices regarding these diseases and mosquitoes.

To participate in this study, you need to be at least 18 years old and live in one of the selected health areas in Kinshasa. If you agree to join, you and your household will be involved in the mosquito control efforts, and your knowledge of these illnesses will be assessed through surveys. The study aims to understand how well these control methods work and to increase awareness about Aedes-borne diseases in the community. Your participation could help improve public health strategies in the region.

Gender

ALL

Eligibility criteria

• At household level:
• Inclusion Criteria:
• • Belong to a household in one of the 4 health areas selected as study arms
• • From 18 years of age to consent for household enrollment and participation in the serosurvey
• • Consenting
• Exclusion Criteria:
• • Not belong to a household in one of the 4 health areas selected as study arms
• • Under 18 years of age
• • Non-consenting
• At health facility level:
• Inclusion Criteria:
• • From 18 years of age
• • Resident of the health zone of Mont Ngafula 1
• • Consenting
• Exclusion Criteria:
• • Under 18 years of age
• • Not resident in the health zone of Mont Ngafula 1
• • Seriously ill and hospitalized, requiring transfusion, presence of blood clotting disorders, allergies resulting from injections, adverse events associated with previous blood sampling, pregnancy
• • Non-consenting